TFF Pharmaceuticals NASDAQ TFFP 2024 Investor Presentation

TFF Pharmaceuticals presents its Thin Film Freezing (TFF) drug delivery platform for inhalational formulations. The company highlights two lead programs—TFF TAC for lung transplantation and TFF VORI for pulmonary fungal infections—both with positive Phase 2 data and potential peak sales exceeding $1 billion annually.